Concord Healthcare Group Co., Ltd IPO Analysis

Concord Healthcare Group Co., Ltd

Concord Healthcare Group Co., Ltd. is an oncology healthcare service provider in China. The company offers a full range of oncology healthcare services to cancer patients, including screening, diagnosis, treatment, and post-treatment health management. They serve both cancer patients through their self-owned medical institutions and third-party medical institutions through their medical equipment, software, and related services. Their mission is to improve the quality of oncology healthcare, especially in lower-tier cities, and alleviate the uneven distribution of critical healthcare resources in China.

Sharlife Shariah Status :

No

IPO Allocation Shares

Allocation	Shares	%
Hong Kong
International

Income Statement

	31/12/2020	31/12/2021	31/12/2022	% Growth
Revenue
Other Income
Interest Income
Profit After Tax
PAT Margin %

Balance Sheet

	31/12/2020	31/12/2021	31/12/2022	% Growth
Non-current Assets
Current Assets
Non Current Liabilities
Current Liabilities
Deferred Liabilities
Total Assets
Total Liabilities

Capital & Reserves

	31/12/2020	31/12/2021	31/12/2022	% Growth
Share Capital
Retained Earnings
Reserves
Working Capital
Shareholder Fund

Ratio

0 = Lowest | 5 = Highest

	31/12/2020	Score	31/12/2021	Score	31/12/2022	Score	% Growth
Current Ratio (Liquidity)
Debt Ratio (Leverage)
Gearing Ratio (Leverage)
Return on Capital Employed
Total Assets Turnover

Altman-Z

31/12/2020	31/12/2021	31/12/2022	Overall weighted score

P/E Comparison

Company P/E ratio

Peers	P/E

Summary Checklist

Checklist	Remarks
Revenue

This section is only for Sharlife subscribers only.

Go to pricing page